Pharmaceutical - Financial

Filter

Current filters:

Financial

Popular Filters

1 to 25 of 1101 results

A$35 million to advance Australian type 1 juvenile diabetes research

A$35 million to advance Australian type 1 juvenile diabetes research

10-07-2014

Australia’s Minister for Education, Christopher Pyne, and Minister for Health, Peter Dutton, have today…

AustraliaDiabetesFinancialPharmaceuticalResearch

New Zealand proposes contestable fund for medicines for rare disorders

New Zealand proposes contestable fund for medicines for rare disorders

09-07-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC will be running a commercial process to fund…

FinancialNew ZealandPharmaceuticalRare diseasesRegulation

Bayer milestone for Compugen in cancer immunotherapy deal

Bayer milestone for Compugen in cancer immunotherapy deal

07-07-2014

Shares of Israel-based Compugen rose nearly 4% in pre-market trading today, after it said it has achieved…

BayerCompugenFinancialOncologyPharmaceuticalResearch

Isis Pharma earns $1 million GSK milestone on hepatitis B virus program

Isis Pharma earns $1 million GSK milestone on hepatitis B virus program

03-07-2014

USA-based Isis Pharmaceuticals has earned yet another $1 million payment from UK pharma giant GlaxoSmithKline,…

Anti-viralsFinancialGlaxoSmithKlineIsis PharmaceuticalsPharmaceuticalResearch

New OECD data shows Australia lagging in investing in medicines

New OECD data shows Australia lagging in investing in medicines

03-07-2014

Data newly released by the Organization for Economic Cooperation and Development (OECD) reveals that…

AustraliaFinancialHealthcarePharmaceutical

Chronic under-reporting of pharma R&D investment works against Canada

Chronic under-reporting of pharma R&D investment works against Canada

30-06-2014

A new KPMG study shows that R&D investments made by Canada's innovative pharmaceutical sector continue…

ApostropheCADCanadaEnglish spellingFinancialPharmaceuticalPharmaceutical sectorPoliticsPunctuationResearch

PhRMA says too many patients can’t access vital medicines

PhRMA says too many patients can’t access vital medicines

30-06-2014

A recent discussion held by the Pharmaceutical Research and Manufacturers of America (PhRMA) has concluded…

FinancialPharmaceuticalUSA

Further Indian drug price cuts, and price control categorization likely

30-06-2014

In order to make drugs more affordable to the country’s public, the Indian government is likely to…

FinancialIndiaPharmaceuticalPoliticsPricing

Smarter research spending would boost French innovation, says OECD

27-06-2014

Encouraging private-sector innovation, making public research institutions more accountable and channelling…

FinancialFrancePharmaceuticalPoliticsResearch

AbbVie justifies its position regarding Shire offer

AbbVie justifies its position regarding Shire offer

26-06-2014

US drugmaker AbbVie has set out its ‘strategic rationale’ for its proposal to buy Ireland headquartered…

AbbVieFinancialPharmaceuticalShire PharmaceuticalsUSA

Modest uptick projected in US health care spending growth rate in 2015

25-06-2014

After a five-year contraction in employer health care spending growth, medical inflation in the USA is…

FinancialHealthcarePharmaceuticalUSA

Another $1 million GSK milestone for Isis Pharma

Another $1 million GSK milestone for Isis Pharma

24-06-2014

USA-based Isis Pharmaceuticals said today that it has earned a $1 million milestone payment from GlaxoSmithKline…

FinancialGlaxoSmithKlineIsis PharmaceuticalsISIS-TTR RxPharmaceuticalRare diseasesResearch

AbbVie raises expectations driven by strong performance

AbbVie raises expectations driven by strong performance

24-06-2014

US drugmaker AbbVie has raised the midpoint of its full-year 2014 earnings-per-share guidance by six…

AbbVieAmortizationBusiness FinanceFinanceFinancialGuidancePharmaceuticalUSAUSD

Vectura earns VR315 US development milestone

24-06-2014

UK developer of inhaled therapies Vectura Group says that it has triggered a milestone of $1.5 million…

FinancialPharmaceuticalResearchRespiratory and PulmonaryVecturaVR315

EIB and UCB partner to accelerate development of new medicines

EIB and UCB partner to accelerate development of new medicines

17-06-2014

The European Investment Bank (EIB), the financing institution of the European Union, has signed an agreement…

EuropeFinancialPharmaceuticalResearchUCB

Brazil’s pharma demands tax exemptions and equality for medical products produced in Brazil

Brazil’s pharma demands tax exemptions and equality for medical products produced in Brazil

16-06-2014

Representatives from the Brazilian pharmaceutical industry last week defended the reduction of taxes…

BrazilFinancialHealthcarePharmaceuticalProduction

Pharma more optimistic about future despite upcoming industry consolidation

Pharma more optimistic about future despite upcoming industry consolidation

13-06-2014

More than 69% of senior players within the pan-world pharma industry expect to see a year-on-year increase…

FinancialGlobalMergers & AcquisitionsPharmaceutical

Italian legislation undermines EU regulatory framework by endorsing off-label drug use for economic reasons

Italian legislation undermines EU regulatory framework by endorsing off-label drug use for economic reasons

11-06-2014

The European Federation of Pharmaceutical Industries and Associations says it is concerned about a decision…

AvastinEuropeFinancialItalyNovartisOphthalmicsPharmaceuticalRegulationRoche

Indian draft guidelines for clinical trial compensation for medical management

Indian draft guidelines for clinical trial compensation for medical management

10-06-2014

India's Ministry of Health has released new and revised draft guidelines on compensation to be paid for…

FinancialIndiaPharmaceuticalResearch

Changes to the funding access criteria for some vaccines in New Zealand

Changes to the funding access criteria for some vaccines in New Zealand

09-06-2014

New Zealand’s Pharmaceutical Management Agency, PHARMAC, this morning announced changes to the funding…

FinancialHealthcareNew ZealandPharmaceuticalVaccines

Stada will continue to develop emerging markets as domestic growth drops

Stada will continue to develop emerging markets as domestic growth drops

05-06-2014

German generic and branded drugmaker Stada Arzneimittel’s executive board chairman, Hartmut Retzlaff,…

Business FinanceBusiness FinanceFinancialGenericsGermanyPharmaceuticalSTADA ArzneimittelSTADA Pharmaceuticals

GlaxoSmithKline in $105 million settlement for mis-selling with 44 US states

GlaxoSmithKline in $105 million settlement for mis-selling with 44 US states

05-06-2014

UK pharma giant GlaxoSmithKline has agreed to a $105 million settlement with 44 US states and the District…

AdvairFinancialGlaxoSmithKlineLegalMarkets & MarketingNeurologicalPaxilPharmaceuticalRespiratory and PulmonaryUSAWellbutrin

1 to 25 of 1101 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top